Trial Profile
A Single-Centre Pilot Trial Investigating the Efficacy and Safety of Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Enobosarm (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- Sponsors HAVAH Therapeutics
- 17 Apr 2018 Status changed from recruiting to completed.
- 01 Sep 2017 New trial record